Neo Kuma psychedelics VC fund interview with Burtenshaw
Neo Kuma Ventures is a new venture fund in London that's just for investing in psychedelics. Psychedelics are mind-altering substances, like the psilocybin found in magic mushrooms. Early research suggests that psychedelics could be used to treat health conditions, like mental illnesses resistant to conventional treatments. Psychedelics is an emerging industry worldwide, separate to cannabis. Canada, the US and Europe are frontrunners. Neo Kuma's 35-year-old co-founder shared her strategy for an emerging and risky field. Clara Burtenshaw had a personal interest in psychedelics that's now ...
Source: businessinsider.com